Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Jul 19 2023

Full Issue

Perspectives: Urgent Action Needed To Curb Opioid Overdoses; Opill Is First Step But More Needs To Be Done

Read recent commentaries about drug-cost issues.

USA Today: Fentanyl Crisis Isn't Slowing. We Must Ramp Up Opioid Addiction Fight

The Centers for Disease Control and Prevention (CDC) estimates that close to a million people have died from opiate overdoses since 1999. That is so many deaths, it has contributed to a decline of the national life expectancy age. (Dr. Thomas K. Lew, 7/18)

Los Angeles Times: Why The First Over-The-Counter Birth Control Pill Is A Hollow Victory 

Last week, the Food and Drug Administration made the progesterone-based Opill (norgestrel) the first hormonal contraceptive approved for over-the-counter sale. Many advocates are celebrating the decision as another landmark triumph for reproductive rights. But in a country with countless obstacles to abortion access — including total or near-total abortion bans in 16 states — the advent of a nonprescription birth control pill is a hollow victory. (Christine Henneberg, 7/19)

The Philadelphia Inquirer: Over-The-Counter Birth Control Pill Is ‘Small Victory’ 

Last Thursday, the Food and Drug Administration made it as easy to get the birth control pill Opill as a bottle of Tylenol. Going forward, Opill will be available over the counter, without a prescription. (Kathryn Kolbert, 7/18)

Houston Chronicle: You’re Not Tripping. Crenshaw And AOC Unite On Psychedelics

What can’t psychedelic drugs do? Research suggests they can help with depression, anxiety and addiction. Anecdotal experience suggests they can help you pretend to enjoy an outdoor-camping-slash-music festival. (7/15)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF